These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 31051017)
21. Novel psoriasis therapies and patient outcomes, Part 3: Systemic medications. Feely MA; Smith BL; Weinberg JM Cutis; 2015 Jul; 96(1):47-53. PubMed ID: 26244353 [TBL] [Abstract][Full Text] [Related]
22. Current and future trends in biomarker discovery and development of companion diagnostics for arthritis. Gibson DS; Bustard MJ; McGeough CM; Murray HA; Crockard MA; McDowell A; Blayney JK; Gardiner PV; Bjourson AJ Expert Rev Mol Diagn; 2015 Feb; 15(2):219-34. PubMed ID: 25455156 [TBL] [Abstract][Full Text] [Related]
23. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil. Grundmann-Kollmann M; Mooser G; Schraeder P; Zollner T; Kaskel P; Ochsendorf F; Boehncke WH; Kerscher M; Kaufmann R; Peter RU J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis. Mease PJ Curr Opin Rheumatol; 2015 Mar; 27(2):127-33. PubMed ID: 25599143 [TBL] [Abstract][Full Text] [Related]
25. Intestinal MicrobiOMICS to define health and disease in human and mice. Serino M; Chabo C; Burcelin R Curr Pharm Biotechnol; 2012 Apr; 13(5):746-58. PubMed ID: 22122483 [TBL] [Abstract][Full Text] [Related]
26. Integrating transcriptome and proteome profiling: Strategies and applications. Kumar D; Bansal G; Narang A; Basak T; Abbas T; Dash D Proteomics; 2016 Oct; 16(19):2533-2544. PubMed ID: 27343053 [TBL] [Abstract][Full Text] [Related]
27. A pathogenetic approach to autoimmune skin disease therapy: psoriasis and biological drugs, unresolved issues, and future directions. Ayroldi E; Bastianelli A; Cannarile L; Petrillo MG; Delfino DV; Fierabracci A Curr Pharm Des; 2011; 17(29):3176-90. PubMed ID: 21864268 [TBL] [Abstract][Full Text] [Related]
28. Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis. Alunno A; Carubbi F; Cafaro G; Pucci G; Battista F; Bartoloni E; Giacomelli R; Schillaci G; Gerli R Expert Opin Biol Ther; 2015; 15(12):1727-37. PubMed ID: 26653110 [TBL] [Abstract][Full Text] [Related]
29. mixOmics: An R package for 'omics feature selection and multiple data integration. Rohart F; Gautier B; Singh A; Lê Cao KA PLoS Comput Biol; 2017 Nov; 13(11):e1005752. PubMed ID: 29099853 [TBL] [Abstract][Full Text] [Related]
30. Research gaps in psoriasis: opportunities for future studies. Ryan C; Korman NJ; Gelfand JM; Lim HW; Elmets CA; Feldman SR; Gottlieb AB; Koo JY; Lebwohl M; Leonardi CL; Van Voorhees AS; Bhushan R; Menter A J Am Acad Dermatol; 2014 Jan; 70(1):146-67. PubMed ID: 24126079 [TBL] [Abstract][Full Text] [Related]
31. Systems biology in inflammatory bowel diseases: on the way to precision medicine. Dovrolis N; Filidou E; Kolios G Ann Gastroenterol; 2019; 32(3):233-246. PubMed ID: 31040620 [TBL] [Abstract][Full Text] [Related]
32. Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review. Canavan TN; Elmets CA; Cantrell WL; Evans JM; Elewski BE Am J Clin Dermatol; 2016 Feb; 17(1):33-47. PubMed ID: 26649440 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of psoriasis with biologics: a survey of dermatological and rheumatological practice at Reims University Hospital]. Adnot-Desanlis L; Brochot P; Eschard JP; Bernard P; Reguiaï Z Ann Dermatol Venereol; 2012 May; 139(5):355-62. PubMed ID: 22578339 [TBL] [Abstract][Full Text] [Related]
34. Recent Development in Omics Studies. Aizat WM; Ismail I; Noor NM Adv Exp Med Biol; 2018; 1102():1-9. PubMed ID: 30382565 [TBL] [Abstract][Full Text] [Related]
35. Omics technologies, data and bioinformatics principles. Schneider MV; Orchard S Methods Mol Biol; 2011; 719():3-30. PubMed ID: 21370077 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics and pharmacogenomics in psoriasis treatment: current challenges and future prospects. Sutherland A; Power RJ; Rahman P; O'Rielly DD Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):923-35. PubMed ID: 27266955 [TBL] [Abstract][Full Text] [Related]
37. Multi-omics approaches to disease. Hasin Y; Seldin M; Lusis A Genome Biol; 2017 May; 18(1):83. PubMed ID: 28476144 [TBL] [Abstract][Full Text] [Related]
38. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review. Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631 [TBL] [Abstract][Full Text] [Related]
39. Anti-cytokine therapy in the treatment of psoriasis. Kupetsky EA; Mathers AR; Ferris LK Cytokine; 2013 Mar; 61(3):704-12. PubMed ID: 23410503 [TBL] [Abstract][Full Text] [Related]